Hepcludex

Active substance bulevirtide
Holder     Gilead Sciences Belgium B.V.
Status Running
Indication for the treatment of chronic hepatitis delta virus (HDV) infection in plasma (or serum) HDVRNA positive adult patients with compensated liver disease
Public documents Approbation
  Information for the patient
  Informed consent
Last update 04/04/2023

 

Last updated on 13/02/2024